ArticleMedicine2020

The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol.

Mosaburo Kainuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.